about
Salvage rates after progression of high-risk neuroblastoma with a soft tissue massPostnatal management of prenatally diagnosed abdominal masses and anomalies.In utero hematopoietic stem cell transplantation: progress toward clinical application.Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model.Experience with retroperitoneal partial nephrectomy in bilateral Wilms tumor.High-dose-rate brachytherapy for vaginal rhabdomyosarcoma using a personalized mold in a 20-month old patient.Citrullinemia type I and hypertrophic pyloric stenosis in a 1-month old male infant.Surgical treatment of pulmonary metastases in pediatric solid tumors.Paratesticular rhabdomyosarcoma: Importance of initial therapy.Pancreaticoduodenectomy for pediatric and adolescent pancreatic malignancy: A single-center retrospective analysis.Intracardiac Low-grade Sarcoma Following Treatment for Ewing Sarcoma.Customized high-dose-rate brachytherapy using MRI planning for vaginal rhabdomyosarcoma.Thyroid neoplasms: incidental findings on extent of disease evaluation CT for other pediatric malignancies.A novel image-based system for risk stratification in patients with desmoplastic small round cell tumor.Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.High level chimerism and donor specific tolerance achieved in the canine model by in utero hematopoietic cell transplantation followed by postnatal minimal conditioning bone marrow transplantationMaintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis
P50
Q36626994-210484DA-C5B3-42EE-9D3A-C93CFE23E149Q37103849-A77775D1-4289-410F-9E5F-572AC1AE5779Q37186933-3F922F43-4FC2-4EBF-BB24-1CD9707A667DQ37486032-C910027F-29A8-4371-ACAA-632EA1563528Q38245509-D0F0C65A-7EEC-437B-ACBE-9DBEE3EF1BC9Q38256934-695EB4E7-B3CB-4A36-9569-7C2C33263CECQ38678781-296FC33E-B895-4BC9-AB2B-A0FEAB28C24AQ39036563-42309F65-597C-4702-A589-9887271871B0Q39147775-75DC51DC-9F24-4436-B572-EBB2AD661F3AQ39147786-0DDCE806-AD3E-4AD4-864F-F7659C71E967Q40433321-001BA692-F381-409F-8CA0-1FF905F016F2Q47782132-39D3870C-E8E6-4F00-A8F0-B591AAFC0E6DQ50770267-8842E9A4-F45A-4221-8B29-7FB568835088Q52616212-7BE0E6D3-95DA-4BF3-82C6-2D92B536FF13Q54543616-258FA827-1120-499C-8136-EC9185292D89Q57458150-450B3A33-E2F5-4415-A18F-23DBBA3C73E4Q58600984-0A7FDB8A-B339-4B35-ABEE-4EEE99F51C91
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Todd E Heaton
@ast
Todd E Heaton
@en
Todd E Heaton
@es
Todd E Heaton
@nl
type
label
Todd E Heaton
@ast
Todd E Heaton
@en
Todd E Heaton
@es
Todd E Heaton
@nl
prefLabel
Todd E Heaton
@ast
Todd E Heaton
@en
Todd E Heaton
@es
Todd E Heaton
@nl
P106
P31
P496
0000-0003-3515-0028